Sheaff Brock Investment Advisors’s Ampio Pharmaceuticals Inc. AMPE Stock Holding History

Sheaff Brock Investment Advisors’s Portfolio AMPE Stock Details AMPE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-190	Closed	-$3K	–	540
2022 Q3	$3K	Hold	190	–	–	﹤0.01%	495
2022 Q2	$10K	Hold	190	–	–	﹤0.01%	497
2022 Q1	$27K	Hold	190	–	–	﹤0.01%	534
2021 Q4	$32K	Buy	190 +33	+21%	+$12.3K	﹤0.01%	540
2021 Q3	$78K	Buy	157 +34	+28%	+$15.8K	0.01%	537
2021 Q2	$62K	Buy	123 +43	+54%	+$23.1K	﹤0.01%	519
2021 Q1	$41K	Hold	80	–	–	﹤0.01%	499
2020 Q4	$38K	Sell	80 -7	-8%	-$2.3K	﹤0.01%	480
2020 Q3	$25K	Buy	87 +4	+5%	+$991	﹤0.01%	454
2020 Q2	$16K	Hold	83	–	–	﹤0.01%	452
2020 Q1	$10K	Buy	+83	New	+$15K	﹤0.01%	410

Other funds holding AMPE

CFO

CVA Family Office Denver, Colorado $950M AUM 20.72% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Courier Capital Buffalo, New York $2B AUM 24.36% 1-Year Est. Return

WWM

Western Wealth Management Golden, Colorado $2.63B AUM 21.3% 1-Year Est. Return

BJL

Brighton Jones LLC Seattle, Washington $2.37B AUM 16.36% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return

ARG

Advisory Resource Group Tulsa, Oklahoma $665M AUM 29.27% 1-Year Est. Return

CCMW

Cypress Capital Management (Wyoming) Sheridan, Wyoming $120M AUM 63.01% 1-Year Est. Return

Sheaff Brock Investment Advisors's AMPE Position: Q4 2022 in Review

Sheaff Brock Investment Advisors sold out of Ampio Pharmaceuticals Inc. (AMPE) in Q4 2022, closing a stake of 190 shares — an estimated $3K sold.

Sheaff Brock Investment Advisors first reported a position in AMPE in Q1 2020 and held it in 11 quarters. The position peaked at $78K in Q3 2021. 32 funds tracked by Wall St. Rank hold AMPE as of Q4 2022.

Sheaff Brock Investment Advisors reported no remaining Ampio Pharmaceuticals Inc. position as of Q4 2022 after selling out during the quarter.
Sheaff Brock Investment Advisors sold 190 Ampio Pharmaceuticals Inc. shares in Q4 2022, an estimated $3K.
Sheaff Brock Investment Advisors first reported a position in Ampio Pharmaceuticals Inc. in Q1 2020 and held it in 11 quarters.
Sheaff Brock Investment Advisors's Ampio Pharmaceuticals Inc. position peaked at $78K in Q3 2021.
32 funds tracked by Wall St. Rank held Ampio Pharmaceuticals Inc. as of Q4 2022.

Based on Sheaff Brock Investment Advisors's 13F filing for Q4 2022, filed 13 Feb 2023.